The University of Chicago Header Logo

Connection

Neil Sengupta to Infliximab

Back to Details
This is a "connection" page, showing publications Neil Sengupta has written about Infliximab.
Neil Sengupta
Connection Strength
0.048
Infliximab
  1. Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease. Clin Gastroenterol Hepatol. 2022 07; 20(7):1579-1587.e2.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.